Hologene 5: A Phase II/III Clinical Trial of Combined Cell and Gene Therapy of Junctional Epidermolysis Bullosa

Overview of attention for article published in Frontiers in Genetics, September 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 26 Mendeley

So far, Altmetric has seen 1 X post from an account with 5,558 followers.

New Research: Hologene 5: A Phase II/III Clinical Trial of Combined Cell and Gene Therapy of Junctional Epidermolysis Bullosa: Epidermolysis bullosa (EB) is a group of devastating genetic diseases characterized by skin and mucosal fragility and… https://t.

01 Sep 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.